NIH-FUNDED RESEARCH
In addition to our commercial operations, Xona Microfluidics performs grant-funded research. We believe focusing on research together with our commercial activities is critical for our success.
Current projects:
Grant #: R43AG072985 Taylor, Anne Marion (PI) 02/2022-01/2024
Funding agency: NIA
Title: Tau mislocalization assay to screen AD therapeutics using compartmentalized chips
The goal of this project is to develop a scalable and reliable cell-based test that models cellular dysfunction in
Alzheimer’s disease. This project is relevant to public health because it seeks to facilitate and speed up
therapeutic discovery to treat Alzheimer’s disease.
Grant #: R21NS109750 Taylor, Anne Marion (PI) 04/2020-03/2022
Funding agency: NINDS
Title: The influence of axonal ER on retrograde synapse loss following axon damage
The goal of this project is to investigate calcium-dependent axon-to-soma signaling following axotomy that causes somatic ER changes and synapse loss.
————————————————————————————————————–
Completed projects:
Grant #: R41NS108895 Taylor, Anne Marion (PI) 09/2018-08/2020
Funding agency: NINDS
Title: A user-friendly microfluidic chip for anti-epileptogenic drug screening
The goal of this grant is to develop a new anti-epileptogenic drug screen using Xona’s patented platform technology.
Grant #: R42MH097377 Taylor, Anne Marion (PI) 05/2013-09/2019
Funding agency: NIMH
Title: A user-friendly scalable microfluidic platform for enhanced neuron-cell culture
The goal of this grant is to develop user-friendly and robust technology for neuron-cell culture including the development of novel technology for human stem cell-derived neurons and to examine and manipulate synapses.
For more information visit: https://reporter.nih.gov/search/o558IfNKaUCrM4NZmQO7TQ/projects?shared=true